|
Efficacy of High-Dose (100 mg daily) Caspofungin
(HD-CASP) Combination Antifungal Therapy in
Cancer Patients with Invasive Fungal Infections
(IFIs): Case-Controlled Observational Analysis
During 2002-2004 (click for details) |
|
|
|
Cumulative Discontinuous Neutropenia Predicts
Risk of Invasive Aspergillosis both during and
after Resolution of Neutropenia in Patients with
Hematologic Malignancy (click for details) |
|
|
|
Combined Galactomannan (GMn), Mannan (Mn),
and Anti-Mannan (AMn) for Diagnosis of Invasive
Fungal Infections (IFI) in Neutropenic Cancer
Patients (Pts) (click for details) |
|
|
|
Analysis of the Role of [18F] Fluorodeoxyglucose
(FDG) Positron Emission Tomography (PET)
Imaging in Early Diagnosis and Management of
Invasive Mold Infections (IMIs) (click for details) |
|
|
|
AIIogeneic Bone Marrow Transplantation with
Reduced Intensity Conditioning for Chronic
Granulomatous Disease Complicated by Invasive
Aspergillus Infection (click for details) |
|
|
|
Beta-l,3-D-Glucan (BGL) Antigenemia in
Neutropenic Cancer Patients (Pts) with Invasive
Aspergillosis (IA) and Candidiasis (IC) (click for details) |
|
|
|
Caspofungin vs. Caspofungin Combined with
Liposomal Amphotericin B for the Treatment of
Cerebral Aspergillosis in a Nursing Rat Model (click for details) |
|
|
|
Comparison of Galactomannan EIA and
Quantitative PCR Performed on BAL Fluid for
Diagnosing of Invasive Pulmonary Aspergillosis
in HSCT Recipients (click for details) |
|
|
|
Invasive Fungal Infections among Pediatric
Patients with Hematologic Malignancies at
KFSH&RC/KFCCC&R (click for details) |
|
|
|
Evaluation of a LightCycler PCR Assay for the
Detection of Invasive Aspergillosis in Pediatric
Patients with Onco-hematological Diseases (click for details) |
|
|
